My first encounter with the acne medication, if you will, occurred at the age of twelve. My grandmother just spotted a huge swollen bubble of a zit on my cheek. At the sight of my horrible facial growth, my grandmother motioned me out of her medicine cabinet and pleaded: "Put turpentine on this flight to suck this poison."
True, turpentine is not an FDA-approved acne medication, but the next morning, this swollen nodule is somehow flattened into healed skin.
Many people tormented by pimples find no respite with trusted terminators such as benzoyl peroxide or antibiotics. And so, researchers work hard in the labs and challenge the endurance of acne-prone skin with yet another preventative treatment against acne. However, this summer, the surrounding innovative anti-acne therapies could make skin blemishes disappear.
Isotretinoin at a reduced dose
For a start, doctors may soon prescribe the drug against acne usually reserved for the most severe. case of cystic or nodular acne, isotretinoin, for mild to moderate acne cases. Last June, a study published in Expert Review of Dermatology showed that a low dose intermittent regimen of isotretinoin could alleviate the potentially caustic side effects of isotretinoin, such as liver damage and extreme skin dryness. Acne Treatment
Bioidentical Anti-Acne Agents
While isotretinoin works by reducing facial oil secretion and bacterial count, a patented bioproduct called phytosphingosine (PS) can fight acne relieving pain causing inflammation.
Phytosphingosine (PS) is a fat that exists in the upper layers of the skin and is called the stratum corneum. According to a report published in International Journal of Cosmetic Science a skin-identical version of phytosphingosine exhibited antibacterial and anti-inflammatory properties in the skin. Researchers suspect that this new anti-acne fat may soon complement topical pimples treatments.
Less Menacing Contraceptives
If these fat-filled topical creams are enough to soothe imperfections care regimen with contraceptives. And with the arrival of a new hormonal agent called drospirenone, women can enjoy less acne and a more enjoyable time.
Physicians may prescribe an oral contraceptive composed of spirolactone and ethinyl estradiol to women over 35 years of age.
Spironolactone, drospirenone, helps control acne by reducing androgenic hormonal activity, such as excessive production of oil for the face. Yet when drospirenone moves spirolactone into such contraceptives, women experience better control of acne and less weight gain and menstrual pain, while still benefiting from the same effective contraceptive control.
Starting with isotretinoin, phytosphingosine or birth control pills, I predict that in one generation, multiple causes and factors contributing to acne lesions will continue to discourage scientists and to continue to clutter our antidote cabinets. In the meantime, "Thank you grandmother."
Pavicic, T; U Wollenweber, M. Farwick & H. Korting. Antimicrobial and inflammatory activity and efficacy of phytosphingosine: an in vitro and in vivo study on acne vulgaris. International Journal of Cosmetic Science June 2007; flight. 29, No. 3, pp. 181-190.
Ramos-e-Silva, M .; C da Silva & S Coelho. Oral isotretinoin: intermittent and low-dose diet in acne. Expert Review of Dermatology June 2007; vol 2, no. 3, pp. 267-269.
Rapkin, A & S Winer. Drospirenone: a new progestin. Expert Opinion on Pharmacotherapy May 2007; Vol 8, No. 7, pp 989-999.